0 CHECKOUT

PRODUCT FILTERS

REGION

49
2
1
1
1

COUNTRY

1

CATEGORIES

  • 17
  • 12
  • 11
  • 9
  • 8
  • 7
  • 7
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

15
21
33
87

PUBLISHED

1
16
25
87

PRODUCT TYPE

66
16
3
1
1

Search for: "European Markets for Parkinson's Disease Therapeutics"

Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

Parkinson's Disease (PD) is a progressive, chronic neurodegenerative condition, which is currently incurable. It is associated with old age, and characterized by the loss of neurons in the substantia...

Published:  February 2016
Price:  From

Global Parkinson’s Disease Market Report: 2016 Edition

Parkinson’s Disease (PD) is a chronic and progressive neurodegenerative or movement disorder which involves the malfunction and death of vital nerve cells in the brain, called neurons. Parkinson’s primarily...

Published:  May 2016
Price:  From

Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management

The Parkinson’s Disease (PD) market is dominated by symptomatic treatments targeting functional impairment in PD Levodopa has remained the gold standard treatment for almost 40 years and has significantly...

Published:  December 2013
Price:  From

Parkinson's Disease Global Clinical Trials Review, H2, 2011

Parkinson’s Disease Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2, 2011" provides data on the Parkinson’s...

Published:  October 2011
Price:  From

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

Published:  February 2015
Price:  From

Alzheimers and Parkinsons Disease - Global Strategic Business Report

This report analyzes the worldwide markets for Alzheimer’s and Parkinson’s Disease in Millions of US$. The Major product segments Analyzed are Anti-Alzheimer’s Disease Drugs (Cholinesterase Inhibitors,...

Published:  May 2008
Price:  From

Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020

Industry Insights Growing geriatric population base and rising incidences of target diseases such as Alzheimer’s and Parkinson’s are the major drivers for this market. As per an estimate by the Alzheimer...

Published:  January 2014
Price:  From

The Neurotechnology Industry 2014 Report

Now in its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments It is the only publication to provide a comprehensive...

Published:  July 2014
Price:  From

Global Neurodegenerative Diseases Market 2015-2019

About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech,...

Published:  May 2015
Price:  From

Deep Brain Stimulation Devices - Global Strategic Business Report

This report analyzes the worldwide markets for Deep Brain Stimulation Devices in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin...

Published:  June 2015
Price:  From

Melanoma Therapeutics Market to 2020

Summary: This report is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and, according to some classifications,...

Published:  September 2014
Price:  From

Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)

Stem cells are anticipated to demonstrate considerable efficacy in clinical treatment and revenues to manufacturers with suitable products.  Kalorama Information’s Stem Cell Therapeutics Markets is...

Published:  October 2014
Price:  From

CNS Drug News Issue 373

Ocrelizumab has blockbuster potential as the first therapeutic to control primary progressive multiple sclerosis. There is a high demand for therapeutics to manage the condition and ocrelizumab will...

Published:  March 2016
Price: 

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From

Gaucher Disease - Pipeline Review, H1 2016

Gaucher Disease - Pipeline Review, H1 2016 Summary ‘Gaucher Disease - Pipeline Review, H1 2016’, provides an overview of the Gaucher Disease pipeline landscape. The report provides comprehensive...

Published:  June 2016
Price:  From

Neurostimulation Devices Market Analysis by Product, by Application and Segment Forecasts to 2020

Neurostimulation Devices Market Analysis By Product (Deep Brain, Gastric Electric, Gastric Electric, Spinal Cord, Sacral Nerve And Vagus Nerve Stimulation Device), By Application (Pain Management, Epilepsy,...

Published:  January 2014
Price:  From

RNAi - Technologies, Markets and Companies

RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used...

Published:  June 2016
Price:  From

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

Published:  June 2016
Price:  From

The Global Market for Stem Cells

The global stem cell market reached over $5.9 billion in 2015 and will grow from about $6.7 billion in 2016 to nearly $12.3 billion in 2021, registering a compound annual growth rate (CAGR) of 13.1%...

Published:  May 2016
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group